| Literature DB >> 31452481 |
Xiaowen Shao1, Guihai Ai1, Lian Wang1, Jinlong Qin1, Yue Li1, Huici Jiang1, Tingting Zhang1, Linlin Zhou1, Zhengliang Gao2, Jiajing Cheng1, Zhongping Cheng1.
Abstract
Endometrial injury is an important cause of intrauterine adhesion (IUA), amenorrhea and infertility in women, with limited effective therapies. Recently, stem cells have been used in animal experiments to repair and improve injured endometrium. To date, our understanding of adipose-derived stem cells (ADSCs) in endometrial injury repair and their further therapeutic mechanisms is incomplete. Here, we examined the benefit of ADSCs in restoration of injured endometrium by applying a rat endometrial injury model. The results revealed by immunofluorescence showed that green fluorescent protein (GFP)-labelled ADSCs can differentiate into endometrial epithelial cells in vivo. At 30 days after ADSCs transplantation, injured endometrium was significantly improved, with increased microvessel density, endometrial thickness and glands when compared with the model group. Furthermore, the fertility of rats with injured endometrium in ADSCs group was improved and had a higher conception rate (60% vs 20%, P = 0.014) compared with the control phosphate-buffered saline (PBS) group. However, there was no difference in the control group compared with the sham group. In addition, expression levels of the oestrogen receptor Eα/β (ERα, ERβ) and progesterone receptor (PR) detected by western blot and enzyme-linked immunosorbent assay (ELISA) were higher in the ADSCs group than in the PBS group. Taken together, these results suggested that ADSC transplantation could improve endometrial injury as a novel therapy for IUA.Entities:
Keywords: Adipose-derived stem cells; Endometrial injury; Regeneration; Stem cell transplantation
Mesh:
Substances:
Year: 2019 PMID: 31452481 DOI: 10.1017/S096719941900042X
Source DB: PubMed Journal: Zygote ISSN: 0967-1994 Impact factor: 1.442